Anna Mikolajczak

7PUBLICATIONS
82CO-AUTHORS
Molecular targetsHaematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2026
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones.

|Feb 05, 2026
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma.

Kane A Foster, Elise Rees, Louise Ainley

|Sep 23, 2025
Type I IFN drives neutrophil swarming, impeding lung T cell-macrophage interactions and TB control.

William J Branchett, Evangelos Stavropoulos, Jessica Shields

|Jan 09, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal.

Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan

|Jan 08, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal.

Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan

|Apr 12, 2024
Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis.

Marisol Alvarez-Martinez, Luke S Cox, Claire F Pearson

Pageof 2

Frequent Collaborators

2 joint publications

Annika Fendler

2 joint publications

Rachael Thompson

2 joint publications

Anne-Laure Cattin

2 joint publications

Ángel Fernández-Sanromán